Long-term efficacy of current thyroid prophylaxis and future perspectives on thyroid protection during 131I-metaiodobenzylguanidine treatment in children with neuroblastoma.

Clement, S C; van Rijn, R R; van Eck-Smit, B L F; van Trotsenburg, A S P; Caron, H N; Tytgat, G A M; van Santen, H M

Clement, S C; van Rijn, R R; van Eck-Smit, B L F; van Trotsenburg, A S P; Caron, H N; Tytgat, G A M; van Santen, H M.

Affiliation

Clement SC; Department of Pediatric Endocrinology, Emma Children's Hospital, Academic Medical Center, University of Amsterdam, PO box 22660, 1100 DD, Amsterdam, The Netherlands, s.c.clement@amc.uva.nl.

Eur J Nucl Med Mol Imaging ; 42(5): 706-15, 2015 Apr.

Article in En | MEDLINE | ID: mdl-25512056

Subject(s)

3-Iodobenzylguanidine/adverse effects; Hypothyroidism/prevention & control; Neoplasms, Radiation-Induced/prevention & control; Neuroblastoma/radiotherapy; Radiopharmaceuticals/adverse effects; Radiotherapy/adverse effects; Thyroid Neoplasms/prevention & control; 3-Iodobenzylguanidine/therapeutic use; Child; Child, Preschool; Female; Humans; Hypothyroidism/etiology; Infant; Male; Neoplasms, Radiation-Induced/etiology; Radiopharmaceuticals/therapeutic use; Thyroid Neoplasms/etiology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Radiotherapy / Thyroid Neoplasms / Radiopharmaceuticals / 3-Iodobenzylguanidine / Hypothyroidism / Neoplasms, Radiation-Induced / Neuroblastoma Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Child / Child, preschool / Female / Humans / Infant / Male Language: En Year: 2015 Type: Article

Fulltext

XML

PubMed Links

Search on Google